184 related articles for article (PubMed ID: 38212807)
21. Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple Mechanisms.
Olmez I; Brenneman B; Xiao A; Serbulea V; Benamar M; Zhang Y; Manigat L; Abbas T; Lee J; Nakano I; Godlewski J; Bronisz A; Abounader R; Leitinger N; Purow B
Clin Cancer Res; 2017 Nov; 23(22):6958-6968. PubMed ID: 28814434
[No Abstract] [Full Text] [Related]
22. Heptamethine Cyanine Dye MHI-148-Mediated Drug Delivery System to Enhance the Anticancer Efficiency of Paclitaxel.
Raveendran A; Poilil Surendran S; Ser J; Alam K; Cho H; Jeong YY
Int J Nanomedicine; 2021; 16():7169-7180. PubMed ID: 34707356
[TBL] [Abstract][Full Text] [Related]
23. Modulation of Mcl-1 sensitizes glioblastoma to TRAIL-induced apoptosis.
Murphy ÁC; Weyhenmeyer B; Noonan J; Kilbride SM; Schimansky S; Loh KP; Kögel D; Letai AG; Prehn JH; Murphy BM
Apoptosis; 2014 Apr; 19(4):629-42. PubMed ID: 24213561
[TBL] [Abstract][Full Text] [Related]
24. TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms.
Rauert H; Stühmer T; Bargou R; Wajant H; Siegmund D
Cell Death Dis; 2011 Aug; 2(8):e194. PubMed ID: 21850048
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of
Rossi AFT; da Silva Manoel-Caetano F; Biselli JM; Cabral ÁS; Saiki MFC; Ribeiro ML; Silva AE
World J Gastroenterol; 2022 Jun; 28(24):2689-2704. PubMed ID: 35979166
[TBL] [Abstract][Full Text] [Related]
26. Ambivalent Effects of Tumor Necrosis Factor Alpha on Apoptosis of Malignant and Normal Human Keratinocytes.
Kokolakis G; Sabat R; Krüger-Krasagakis S; Eberle J
Skin Pharmacol Physiol; 2021; 34(2):94-102. PubMed ID: 33730739
[TBL] [Abstract][Full Text] [Related]
27. Role of heme oxygenase 1 in TNF/TNF receptor-mediated apoptosis after hepatic ischemia/reperfusion in rats.
Kim SJ; Eum HA; Billiar TR; Lee SM
Shock; 2013 Apr; 39(4):380-8. PubMed ID: 23423194
[TBL] [Abstract][Full Text] [Related]
28. Regulation of cytokine-induced neuron death by ovarian hormones: involvement of antiapoptotic protein expression and c-JUN N-terminal kinase-mediated proapoptotic signaling.
Koski CL; Hila S; Hoffman GE
Endocrinology; 2004 Jan; 145(1):95-103. PubMed ID: 14512437
[TBL] [Abstract][Full Text] [Related]
29. Palbociclib Effectively Halts Proliferation but Fails to Induce Senescence in Patient-Derived Glioma Stem Cells.
Morris-Hanon O; Marazita MC; Romorini L; Isaja L; Fernandez-Espinosa DD; Sevlever GE; Scassa ME; Videla-Richardson GA
Mol Neurobiol; 2019 Nov; 56(11):7810-7821. PubMed ID: 31124078
[TBL] [Abstract][Full Text] [Related]
30. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
You BR; Han BR; Park WH
Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
[TBL] [Abstract][Full Text] [Related]
31. Potent anti-tumor efficacy of palbociclib in treatment-naïve H3.3K27M-mutant diffuse intrinsic pontine glioma.
Sun Y; Sun Y; Yan K; Li Z; Xu C; Geng Y; Pan C; Chen X; Zhang L; Xi Q
EBioMedicine; 2019 May; 43():171-179. PubMed ID: 31060906
[TBL] [Abstract][Full Text] [Related]
32. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
[TBL] [Abstract][Full Text] [Related]
33. Tumour necrosis factor receptors and apoptosis of alveolar macrophages during early infection with attenuated and virulent Mycobacterium bovis.
Rodrigues MF; Alves CC; Figueiredo BB; Rezende AB; Wohlres-Viana S; Silva VL; Machado MA; Teixeira HC
Immunology; 2013 Aug; 139(4):503-12. PubMed ID: 23489296
[TBL] [Abstract][Full Text] [Related]
34. Mechanistic Investigation of Bone Marrow Suppression Associated with Palbociclib and its Differentiation from Cytotoxic Chemotherapies.
Hu W; Sung T; Jessen BA; Thibault S; Finkelstein MB; Khan NK; Sacaan AI
Clin Cancer Res; 2016 Apr; 22(8):2000-8. PubMed ID: 26631614
[TBL] [Abstract][Full Text] [Related]
35. Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer.
Kettner NM; Vijayaraghavan S; Durak MG; Bui T; Kohansal M; Ha MJ; Liu B; Rao X; Wang J; Yi M; Carey JPW; Chen X; Eckols TK; Raghavendra AS; Ibrahim NK; Karuturi MS; Watowich SS; Sahin A; Tweardy DJ; Hunt KK; Tripathy D; Keyomarsi K
Clin Cancer Res; 2019 Jul; 25(13):3996-4013. PubMed ID: 30867218
[TBL] [Abstract][Full Text] [Related]
36. Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics.
Pandey K; Lee E; Park N; Hur J; Cho YB; Katuwal NB; Kim SK; Lee SA; Kim I; An HJ; Hwang S; Moon YW
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33504001
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss.
Gao Y; Shen J; Choy E; Mankin H; Hornicek F; Duan Z
Cell Oncol (Dordr); 2017 Jun; 40(3):209-218. PubMed ID: 28243976
[TBL] [Abstract][Full Text] [Related]
38. NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis.
Boutaffala L; Bertrand MJ; Remouchamps C; Seleznik G; Reisinger F; Janas M; Bénézech C; Fernandes MT; Marchetti S; Mair F; Ganeff C; Hupalowska A; Ricci JE; Becher B; Piette J; Knolle P; Caamano J; Vandenabeele P; Heikenwalder M; Dejardin E
Cell Death Differ; 2015 Dec; 22(12):2020-33. PubMed ID: 26045047
[TBL] [Abstract][Full Text] [Related]
39. Suppression of the invasive potential of Glioblastoma cells by mTOR inhibitors involves modulation of NFκB and PKC-α signaling.
Chandrika G; Natesh K; Ranade D; Chugh A; Shastry P
Sci Rep; 2016 Mar; 6():22455. PubMed ID: 26940200
[TBL] [Abstract][Full Text] [Related]
40. Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma.
Wang TH; Chen CC; Leu YL; Lee YS; Lian JH; Hsieh HL; Chen CY
J Formos Med Assoc; 2021 Sep; 120(9):1695-1705. PubMed ID: 33342707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
